Researchers find that men with male pattern baldness may be at higher
risk for developing aggressive prostate cancer compared with men who are not
bald or balding.
by John
Tyburski
Copyright © Daily
Digest News, KPR Media, LLC. All rights reserved.
According
to the Centers for Disease Control and Prevention, prostate cancer is the most common type
of cancer for men of all races in the United States and occurs at a rate of
about 128 cases per 100,000 at-risk males. That is nearly twice the rate of
male lung cancer and three times the rate of colorectal cancer in men.
Although
black men tend to have somewhat higher incident cases, risk factors and
indicators of prostate cancer have otherwise remained elusive. A new study
suggests that male pattern baldness may in fact turn out to be a predictor of
an aggressive form of prostate cancer. The report that describes the study was published in the
September 15 issue of the Journal of Clinical Oncology.
Michael
Cook, an epidemiologist in the National Cancer Institute’s Division of Cancer
Epidemiology and Genetics, and his colleagues explored whether men who took
part in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening
Trial exhibited an association between male pattern baldness and prostate
cancer, as the two conditions “appear to share common pathophysiologic
mechanisms,” according to the report.
Cook and
coworkers included just over 39,000 men in the PLCO cohort between the ages of
55 and 74 who recalled their hair-loss patterns. The men had no cancer
diagnoses when they enrolled, and their hair-loss recall was for their 45th
year of life. Approximately 18 percent of the men recalled having male pattern
baldness at 45. Over 1,100 men were eventually diagnosed with prostate cancer,
and nearly 600 of these cases involved aggressive prostate cancer.
Compared
with no baldness, baldness on the front and moderate crown baldness were
associated with increased risk of aggressive prostate cancer later in life. The
risk for men with baldness at 45 to develop aggressive prostate cancer was
about 39 percent higher than for men with little or no balding. When
considering all types of prostate cancer together or only nonaggressive
prostate cancer, however, the associations were insignificant.
“It is
conceivable that, in the future, male pattern baldness may play a small role in
estimating risk of prostate cancer and may contribute to discussions between
doctors and patients about prostate cancer screening,” said Cook.